nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—Ifosfamide—germ cell cancer	0.685	1	CrCtD
Cyclophosphamide—CYP2C18—Ifosfamide—germ cell cancer	0.0481	0.222	CbGbCtD
Cyclophosphamide—CYP2A6—Ifosfamide—germ cell cancer	0.0234	0.108	CbGbCtD
Cyclophosphamide—CYP3A7—Ifosfamide—germ cell cancer	0.016	0.0739	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.016	0.0739	CbGbCtD
Cyclophosphamide—CYP2B6—Ifosfamide—germ cell cancer	0.0152	0.0703	CbGbCtD
Cyclophosphamide—CYP3A5—Ifosfamide—germ cell cancer	0.012	0.0554	CbGbCtD
Cyclophosphamide—CYP2C8—Ifosfamide—germ cell cancer	0.0115	0.0533	CbGbCtD
Cyclophosphamide—CYP2C19—Ifosfamide—germ cell cancer	0.00966	0.0447	CbGbCtD
Cyclophosphamide—CYP2C9—Ifosfamide—germ cell cancer	0.00803	0.0372	CbGbCtD
Cyclophosphamide—CYP2B6—Cisplatin—germ cell cancer	0.00739	0.0342	CbGbCtD
Cyclophosphamide—ABCB1—Dactinomycin—germ cell cancer	0.0066	0.0305	CbGbCtD
Cyclophosphamide—CYP3A5—Etoposide—germ cell cancer	0.00572	0.0265	CbGbCtD
Cyclophosphamide—CYP2C8—Etoposide—germ cell cancer	0.0055	0.0255	CbGbCtD
Cyclophosphamide—CYP3A4—Ifosfamide—germ cell cancer	0.00467	0.0216	CbGbCtD
Cyclophosphamide—ABCB1—Vinblastine—germ cell cancer	0.00413	0.0191	CbGbCtD
Cyclophosphamide—CYP2C9—Cisplatin—germ cell cancer	0.00391	0.0181	CbGbCtD
Cyclophosphamide—CYP2D6—Vinblastine—germ cell cancer	0.0039	0.018	CbGbCtD
Cyclophosphamide—ABCB1—Cisplatin—germ cell cancer	0.00379	0.0175	CbGbCtD
Cyclophosphamide—ABCB1—Etoposide—germ cell cancer	0.00373	0.0172	CbGbCtD
Cyclophosphamide—CYP3A4—Vinblastine—germ cell cancer	0.00248	0.0115	CbGbCtD
Cyclophosphamide—ABCB1—Methotrexate—germ cell cancer	0.00246	0.0114	CbGbCtD
Cyclophosphamide—CYP3A4—Etoposide—germ cell cancer	0.00223	0.0103	CbGbCtD
Cyclophosphamide—CYP2C9—cardial valve—germ cell cancer	0.000414	0.282	CbGeAlD
Cyclophosphamide—CYP2C19—urine—germ cell cancer	0.000115	0.0784	CbGeAlD
Cyclophosphamide—CYP2C9—urine—germ cell cancer	8.93e-05	0.0608	CbGeAlD
Cyclophosphamide—CYP3A4—urine—germ cell cancer	6.81e-05	0.0463	CbGeAlD
Cyclophosphamide—CYP2D6—urine—germ cell cancer	6.7e-05	0.0456	CbGeAlD
Cyclophosphamide—Myalgia—Bleomycin—germ cell cancer	4.71e-05	0.000485	CcSEcCtD
Cyclophosphamide—Renal failure—Etoposide—germ cell cancer	4.7e-05	0.000484	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Etoposide—germ cell cancer	4.69e-05	0.000483	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Etoposide—germ cell cancer	4.69e-05	0.000483	CcSEcCtD
Cyclophosphamide—Stomatitis—Etoposide—germ cell cancer	4.66e-05	0.00048	CcSEcCtD
Cyclophosphamide—Jaundice—Etoposide—germ cell cancer	4.66e-05	0.00048	CcSEcCtD
Cyclophosphamide—Discomfort—Bleomycin—germ cell cancer	4.66e-05	0.00048	CcSEcCtD
Cyclophosphamide—Malaise—Dactinomycin—germ cell cancer	4.65e-05	0.00048	CcSEcCtD
Cyclophosphamide—Decreased appetite—Vinblastine—germ cell cancer	4.65e-05	0.000479	CcSEcCtD
Cyclophosphamide—Neoplasm—Methotrexate—germ cell cancer	4.63e-05	0.000477	CcSEcCtD
Cyclophosphamide—Bladder pain—Methotrexate—germ cell cancer	4.63e-05	0.000477	CcSEcCtD
Cyclophosphamide—Mouth ulceration—Methotrexate—germ cell cancer	4.63e-05	0.000477	CcSEcCtD
Cyclophosphamide—Leukopenia—Dactinomycin—germ cell cancer	4.62e-05	0.000476	CcSEcCtD
Cyclophosphamide—Constipation—Vinblastine—germ cell cancer	4.57e-05	0.000471	CcSEcCtD
Cyclophosphamide—Pain—Vinblastine—germ cell cancer	4.57e-05	0.000471	CcSEcCtD
Cyclophosphamide—Pulmonary oedema—Methotrexate—germ cell cancer	4.56e-05	0.000469	CcSEcCtD
Cyclophosphamide—Confusional state—Bleomycin—germ cell cancer	4.55e-05	0.000469	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Bleomycin—germ cell cancer	4.52e-05	0.000465	CcSEcCtD
Cyclophosphamide—Oedema—Bleomycin—germ cell cancer	4.52e-05	0.000465	CcSEcCtD
Cyclophosphamide—Visual impairment—Cisplatin—germ cell cancer	4.51e-05	0.000465	CcSEcCtD
Cyclophosphamide—CYP2C18—endocrine gland—germ cell cancer	4.49e-05	0.0306	CbGeAlD
Cyclophosphamide—Infection—Bleomycin—germ cell cancer	4.49e-05	0.000462	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Etoposide—germ cell cancer	4.46e-05	0.00046	CcSEcCtD
Cyclophosphamide—Vision blurred—Ifosfamide—germ cell cancer	4.46e-05	0.000459	CcSEcCtD
Cyclophosphamide—Sepsis—Methotrexate—germ cell cancer	4.44e-05	0.000458	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Bleomycin—germ cell cancer	4.42e-05	0.000456	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Vinblastine—germ cell cancer	4.41e-05	0.000454	CcSEcCtD
Cyclophosphamide—Myalgia—Dactinomycin—germ cell cancer	4.39e-05	0.000453	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Ifosfamide—germ cell cancer	4.39e-05	0.000452	CcSEcCtD
Cyclophosphamide—Anaemia—Ifosfamide—germ cell cancer	4.37e-05	0.00045	CcSEcCtD
Cyclophosphamide—Tinnitus—Cisplatin—germ cell cancer	4.37e-05	0.00045	CcSEcCtD
Cyclophosphamide—Flushing—Cisplatin—germ cell cancer	4.35e-05	0.000448	CcSEcCtD
Cyclophosphamide—Agitation—Ifosfamide—germ cell cancer	4.35e-05	0.000448	CcSEcCtD
Cyclophosphamide—Discomfort—Dactinomycin—germ cell cancer	4.34e-05	0.000447	CcSEcCtD
Cyclophosphamide—Anorexia—Bleomycin—germ cell cancer	4.31e-05	0.000444	CcSEcCtD
Cyclophosphamide—CYP3A7—endocrine gland—germ cell cancer	4.27e-05	0.0291	CbGeAlD
Cyclophosphamide—Diabetes mellitus—Methotrexate—germ cell cancer	4.27e-05	0.00044	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Etoposide—germ cell cancer	4.27e-05	0.00044	CcSEcCtD
Cyclophosphamide—Malaise—Ifosfamide—germ cell cancer	4.27e-05	0.000439	CcSEcCtD
Cyclophosphamide—Leukopenia—Ifosfamide—germ cell cancer	4.23e-05	0.000436	CcSEcCtD
Cyclophosphamide—Polyuria—Methotrexate—germ cell cancer	4.23e-05	0.000436	CcSEcCtD
Cyclophosphamide—Hypotension—Bleomycin—germ cell cancer	4.22e-05	0.000435	CcSEcCtD
Cyclophosphamide—Oedema—Dactinomycin—germ cell cancer	4.21e-05	0.000434	CcSEcCtD
Cyclophosphamide—Infection—Dactinomycin—germ cell cancer	4.18e-05	0.000431	CcSEcCtD
Cyclophosphamide—Arrhythmia—Cisplatin—germ cell cancer	4.18e-05	0.000431	CcSEcCtD
Cyclophosphamide—Palpitations—Ifosfamide—germ cell cancer	4.18e-05	0.000431	CcSEcCtD
Cyclophosphamide—Alopecia—Cisplatin—germ cell cancer	4.14e-05	0.000426	CcSEcCtD
Cyclophosphamide—Hepatic failure—Methotrexate—germ cell cancer	4.13e-05	0.000426	CcSEcCtD
Cyclophosphamide—Cough—Ifosfamide—germ cell cancer	4.13e-05	0.000425	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Dactinomycin—germ cell cancer	4.12e-05	0.000425	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	4.11e-05	0.000424	CcSEcCtD
Cyclophosphamide—Convulsion—Ifosfamide—germ cell cancer	4.1e-05	0.000422	CcSEcCtD
Cyclophosphamide—Hypertension—Ifosfamide—germ cell cancer	4.08e-05	0.000421	CcSEcCtD
Cyclophosphamide—Erythema—Cisplatin—germ cell cancer	4.08e-05	0.00042	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Etoposide—germ cell cancer	4.06e-05	0.000418	CcSEcCtD
Cyclophosphamide—Paraesthesia—Bleomycin—germ cell cancer	4.06e-05	0.000418	CcSEcCtD
Cyclophosphamide—Dyspnoea—Bleomycin—germ cell cancer	4.03e-05	0.000415	CcSEcCtD
Cyclophosphamide—Chest pain—Ifosfamide—germ cell cancer	4.03e-05	0.000415	CcSEcCtD
Cyclophosphamide—Myalgia—Ifosfamide—germ cell cancer	4.03e-05	0.000415	CcSEcCtD
Cyclophosphamide—Arthralgia—Ifosfamide—germ cell cancer	4.03e-05	0.000415	CcSEcCtD
Cyclophosphamide—Renal failure acute—Methotrexate—germ cell cancer	4.02e-05	0.000415	CcSEcCtD
Cyclophosphamide—Anorexia—Dactinomycin—germ cell cancer	4.02e-05	0.000414	CcSEcCtD
Cyclophosphamide—Flushing—Etoposide—germ cell cancer	3.98e-05	0.00041	CcSEcCtD
Cyclophosphamide—Discomfort—Ifosfamide—germ cell cancer	3.98e-05	0.00041	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Vinblastine—germ cell cancer	3.94e-05	0.000406	CcSEcCtD
Cyclophosphamide—Decreased appetite—Bleomycin—germ cell cancer	3.93e-05	0.000405	CcSEcCtD
Cyclophosphamide—Muscle spasms—Cisplatin—germ cell cancer	3.92e-05	0.000404	CcSEcCtD
Cyclophosphamide—Confusional state—Ifosfamide—germ cell cancer	3.89e-05	0.000401	CcSEcCtD
Cyclophosphamide—Pain—Bleomycin—germ cell cancer	3.86e-05	0.000398	CcSEcCtD
Cyclophosphamide—Oedema—Ifosfamide—germ cell cancer	3.86e-05	0.000398	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Ifosfamide—germ cell cancer	3.86e-05	0.000398	CcSEcCtD
Cyclophosphamide—Chills—Etoposide—germ cell cancer	3.85e-05	0.000397	CcSEcCtD
Cyclophosphamide—Vision blurred—Cisplatin—germ cell cancer	3.84e-05	0.000396	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	3.84e-05	0.000395	CcSEcCtD
Cyclophosphamide—Asthenia—Vinblastine—germ cell cancer	3.84e-05	0.000395	CcSEcCtD
Cyclophosphamide—Infection—Ifosfamide—germ cell cancer	3.83e-05	0.000395	CcSEcCtD
Cyclophosphamide—Tremor—Cisplatin—germ cell cancer	3.82e-05	0.000394	CcSEcCtD
Cyclophosphamide—Alopecia—Etoposide—germ cell cancer	3.79e-05	0.000391	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Cisplatin—germ cell cancer	3.78e-05	0.00039	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Ifosfamide—germ cell cancer	3.78e-05	0.000389	CcSEcCtD
Cyclophosphamide—Anaemia—Cisplatin—germ cell cancer	3.77e-05	0.000388	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Ifosfamide—germ cell cancer	3.73e-05	0.000384	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Bleomycin—germ cell cancer	3.72e-05	0.000383	CcSEcCtD
Cyclophosphamide—Anorexia—Ifosfamide—germ cell cancer	3.68e-05	0.000379	CcSEcCtD
Cyclophosphamide—Malaise—Cisplatin—germ cell cancer	3.68e-05	0.000379	CcSEcCtD
Cyclophosphamide—Decreased appetite—Dactinomycin—germ cell cancer	3.66e-05	0.000377	CcSEcCtD
Cyclophosphamide—Diarrhoea—Vinblastine—germ cell cancer	3.66e-05	0.000377	CcSEcCtD
Cyclophosphamide—Dysgeusia—Etoposide—germ cell cancer	3.66e-05	0.000377	CcSEcCtD
Cyclophosphamide—Leukopenia—Cisplatin—germ cell cancer	3.65e-05	0.000376	CcSEcCtD
Cyclophosphamide—Fatigue—Dactinomycin—germ cell cancer	3.63e-05	0.000374	CcSEcCtD
Cyclophosphamide—Hypotension—Ifosfamide—germ cell cancer	3.61e-05	0.000372	CcSEcCtD
Cyclophosphamide—Pain—Dactinomycin—germ cell cancer	3.6e-05	0.000371	CcSEcCtD
Cyclophosphamide—Muscle spasms—Etoposide—germ cell cancer	3.59e-05	0.00037	CcSEcCtD
Cyclophosphamide—Urticaria—Bleomycin—germ cell cancer	3.59e-05	0.00037	CcSEcCtD
Cyclophosphamide—Body temperature increased—Bleomycin—germ cell cancer	3.57e-05	0.000368	CcSEcCtD
Cyclophosphamide—Dizziness—Vinblastine—germ cell cancer	3.54e-05	0.000364	CcSEcCtD
Cyclophosphamide—Convulsion—Cisplatin—germ cell cancer	3.53e-05	0.000364	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	3.52e-05	0.000362	CcSEcCtD
Cyclophosphamide—Myalgia—Cisplatin—germ cell cancer	3.47e-05	0.000358	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Dactinomycin—germ cell cancer	3.47e-05	0.000358	CcSEcCtD
Cyclophosphamide—Paraesthesia—Ifosfamide—germ cell cancer	3.47e-05	0.000357	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Etoposide—germ cell cancer	3.47e-05	0.000357	CcSEcCtD
Cyclophosphamide—Anaemia—Etoposide—germ cell cancer	3.45e-05	0.000356	CcSEcCtD
Cyclophosphamide—Dyspnoea—Ifosfamide—germ cell cancer	3.44e-05	0.000355	CcSEcCtD
Cyclophosphamide—Discomfort—Cisplatin—germ cell cancer	3.43e-05	0.000353	CcSEcCtD
Cyclophosphamide—Vomiting—Vinblastine—germ cell cancer	3.4e-05	0.00035	CcSEcCtD
Cyclophosphamide—Malaise—Etoposide—germ cell cancer	3.37e-05	0.000347	CcSEcCtD
Cyclophosphamide—Decreased appetite—Ifosfamide—germ cell cancer	3.36e-05	0.000346	CcSEcCtD
Cyclophosphamide—Headache—Vinblastine—germ cell cancer	3.35e-05	0.000345	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	3.35e-05	0.000345	CcSEcCtD
Cyclophosphamide—Leukopenia—Etoposide—germ cell cancer	3.34e-05	0.000345	CcSEcCtD
Cyclophosphamide—Body temperature increased—Dactinomycin—germ cell cancer	3.33e-05	0.000343	CcSEcCtD
Cyclophosphamide—Fatigue—Ifosfamide—germ cell cancer	3.33e-05	0.000343	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Cisplatin—germ cell cancer	3.33e-05	0.000343	CcSEcCtD
Cyclophosphamide—Oedema—Cisplatin—germ cell cancer	3.33e-05	0.000343	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Bleomycin—germ cell cancer	3.33e-05	0.000343	CcSEcCtD
Cyclophosphamide—Infection—Cisplatin—germ cell cancer	3.31e-05	0.000341	CcSEcCtD
Cyclophosphamide—Constipation—Ifosfamide—germ cell cancer	3.3e-05	0.00034	CcSEcCtD
Cyclophosphamide—Pain—Ifosfamide—germ cell cancer	3.3e-05	0.00034	CcSEcCtD
Cyclophosphamide—Cough—Etoposide—germ cell cancer	3.26e-05	0.000336	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Cisplatin—germ cell cancer	3.26e-05	0.000336	CcSEcCtD
Cyclophosphamide—Tachycardia—Cisplatin—germ cell cancer	3.25e-05	0.000335	CcSEcCtD
Cyclophosphamide—Asthenia—Bleomycin—germ cell cancer	3.24e-05	0.000334	CcSEcCtD
Cyclophosphamide—Convulsion—Etoposide—germ cell cancer	3.24e-05	0.000333	CcSEcCtD
Cyclophosphamide—Hypertension—Etoposide—germ cell cancer	3.23e-05	0.000332	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Cisplatin—germ cell cancer	3.22e-05	0.000331	CcSEcCtD
Cyclophosphamide—Pruritus—Bleomycin—germ cell cancer	3.2e-05	0.000329	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Ifosfamide—germ cell cancer	3.18e-05	0.000328	CcSEcCtD
Cyclophosphamide—Chest pain—Etoposide—germ cell cancer	3.18e-05	0.000328	CcSEcCtD
Cyclophosphamide—Nausea—Vinblastine—germ cell cancer	3.18e-05	0.000327	CcSEcCtD
Cyclophosphamide—Anorexia—Cisplatin—germ cell cancer	3.17e-05	0.000327	CcSEcCtD
Cyclophosphamide—Discomfort—Etoposide—germ cell cancer	3.14e-05	0.000324	CcSEcCtD
Cyclophosphamide—Hypotension—Cisplatin—germ cell cancer	3.11e-05	0.00032	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Dactinomycin—germ cell cancer	3.1e-05	0.00032	CcSEcCtD
Cyclophosphamide—Abdominal discomfort—Methotrexate—germ cell cancer	3.08e-05	0.000317	CcSEcCtD
Cyclophosphamide—Confusional state—Etoposide—germ cell cancer	3.07e-05	0.000317	CcSEcCtD
Cyclophosphamide—Urticaria—Ifosfamide—germ cell cancer	3.07e-05	0.000316	CcSEcCtD
Cyclophosphamide—Body temperature increased—Ifosfamide—germ cell cancer	3.05e-05	0.000314	CcSEcCtD
Cyclophosphamide—Pancytopenia—Methotrexate—germ cell cancer	3.05e-05	0.000314	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Etoposide—germ cell cancer	3.05e-05	0.000314	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	3.03e-05	0.000312	CcSEcCtD
Cyclophosphamide—Infection—Etoposide—germ cell cancer	3.03e-05	0.000312	CcSEcCtD
Cyclophosphamide—Asthenia—Dactinomycin—germ cell cancer	3.02e-05	0.000311	CcSEcCtD
Cyclophosphamide—Paraesthesia—Cisplatin—germ cell cancer	2.99e-05	0.000308	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Etoposide—germ cell cancer	2.98e-05	0.000308	CcSEcCtD
Cyclophosphamide—Tachycardia—Etoposide—germ cell cancer	2.98e-05	0.000307	CcSEcCtD
Cyclophosphamide—Dyspnoea—Cisplatin—germ cell cancer	2.97e-05	0.000306	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Etoposide—germ cell cancer	2.95e-05	0.000304	CcSEcCtD
Cyclophosphamide—Anorexia—Etoposide—germ cell cancer	2.91e-05	0.000299	CcSEcCtD
Cyclophosphamide—Decreased appetite—Cisplatin—germ cell cancer	2.89e-05	0.000298	CcSEcCtD
Cyclophosphamide—Diarrhoea—Dactinomycin—germ cell cancer	2.88e-05	0.000297	CcSEcCtD
Cyclophosphamide—Pneumonia—Methotrexate—germ cell cancer	2.88e-05	0.000297	CcSEcCtD
Cyclophosphamide—Vomiting—Bleomycin—germ cell cancer	2.87e-05	0.000296	CcSEcCtD
Cyclophosphamide—Hypotension—Etoposide—germ cell cancer	2.85e-05	0.000294	CcSEcCtD
Cyclophosphamide—Rash—Bleomycin—germ cell cancer	2.85e-05	0.000293	CcSEcCtD
Cyclophosphamide—Pain—Cisplatin—germ cell cancer	2.85e-05	0.000293	CcSEcCtD
Cyclophosphamide—Dermatitis—Bleomycin—germ cell cancer	2.85e-05	0.000293	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Ifosfamide—germ cell cancer	2.84e-05	0.000293	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	2.84e-05	0.000292	CcSEcCtD
Cyclophosphamide—Renal failure—Methotrexate—germ cell cancer	2.81e-05	0.00029	CcSEcCtD
Cyclophosphamide—Stomatitis—Methotrexate—germ cell cancer	2.79e-05	0.000288	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Methotrexate—germ cell cancer	2.78e-05	0.000287	CcSEcCtD
Cyclophosphamide—Asthenia—Ifosfamide—germ cell cancer	2.77e-05	0.000285	CcSEcCtD
Cyclophosphamide—Sweating—Methotrexate—germ cell cancer	2.74e-05	0.000283	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Cisplatin—germ cell cancer	2.74e-05	0.000283	CcSEcCtD
Cyclophosphamide—Paraesthesia—Etoposide—germ cell cancer	2.74e-05	0.000282	CcSEcCtD
Cyclophosphamide—Pruritus—Ifosfamide—germ cell cancer	2.73e-05	0.000281	CcSEcCtD
Cyclophosphamide—Haematuria—Methotrexate—germ cell cancer	2.73e-05	0.000281	CcSEcCtD
Cyclophosphamide—Dyspnoea—Etoposide—germ cell cancer	2.72e-05	0.00028	CcSEcCtD
Cyclophosphamide—Nausea—Bleomycin—germ cell cancer	2.68e-05	0.000276	CcSEcCtD
Cyclophosphamide—Vomiting—Dactinomycin—germ cell cancer	2.68e-05	0.000276	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Methotrexate—germ cell cancer	2.67e-05	0.000275	CcSEcCtD
Cyclophosphamide—Rash—Dactinomycin—germ cell cancer	2.66e-05	0.000274	CcSEcCtD
Cyclophosphamide—Decreased appetite—Etoposide—germ cell cancer	2.65e-05	0.000273	CcSEcCtD
Cyclophosphamide—Diarrhoea—Ifosfamide—germ cell cancer	2.64e-05	0.000272	CcSEcCtD
Cyclophosphamide—Body temperature increased—Cisplatin—germ cell cancer	2.63e-05	0.000271	CcSEcCtD
Cyclophosphamide—Fatigue—Etoposide—germ cell cancer	2.63e-05	0.000271	CcSEcCtD
Cyclophosphamide—CYP2A6—cerebellum—germ cell cancer	2.62e-05	0.0178	CbGeAlD
Cyclophosphamide—ABCB1—blood vessel—germ cell cancer	2.61e-05	0.0178	CbGeAlD
Cyclophosphamide—Pain—Etoposide—germ cell cancer	2.61e-05	0.000269	CcSEcCtD
Cyclophosphamide—Constipation—Etoposide—germ cell cancer	2.61e-05	0.000269	CcSEcCtD
Cyclophosphamide—Haemoglobin—Methotrexate—germ cell cancer	2.58e-05	0.000266	CcSEcCtD
Cyclophosphamide—Haemorrhage—Methotrexate—germ cell cancer	2.57e-05	0.000265	CcSEcCtD
Cyclophosphamide—Hepatitis—Methotrexate—germ cell cancer	2.57e-05	0.000265	CcSEcCtD
Cyclophosphamide—Dizziness—Ifosfamide—germ cell cancer	2.55e-05	0.000263	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Etoposide—germ cell cancer	2.51e-05	0.000259	CcSEcCtD
Cyclophosphamide—Nausea—Dactinomycin—germ cell cancer	2.5e-05	0.000258	CcSEcCtD
Cyclophosphamide—Visual impairment—Methotrexate—germ cell cancer	2.48e-05	0.000255	CcSEcCtD
Cyclophosphamide—Vomiting—Ifosfamide—germ cell cancer	2.45e-05	0.000253	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Cisplatin—germ cell cancer	2.45e-05	0.000253	CcSEcCtD
Cyclophosphamide—Rash—Ifosfamide—germ cell cancer	2.43e-05	0.000251	CcSEcCtD
Cyclophosphamide—Dermatitis—Ifosfamide—germ cell cancer	2.43e-05	0.000251	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Methotrexate—germ cell cancer	2.43e-05	0.00025	CcSEcCtD
Cyclophosphamide—Urticaria—Etoposide—germ cell cancer	2.42e-05	0.00025	CcSEcCtD
Cyclophosphamide—Body temperature increased—Etoposide—germ cell cancer	2.41e-05	0.000248	CcSEcCtD
Cyclophosphamide—Tinnitus—Methotrexate—germ cell cancer	2.4e-05	0.000247	CcSEcCtD
Cyclophosphamide—Asthenia—Cisplatin—germ cell cancer	2.39e-05	0.000246	CcSEcCtD
Cyclophosphamide—Chills—Methotrexate—germ cell cancer	2.31e-05	0.000238	CcSEcCtD
Cyclophosphamide—Nausea—Ifosfamide—germ cell cancer	2.29e-05	0.000236	CcSEcCtD
Cyclophosphamide—Diarrhoea—Cisplatin—germ cell cancer	2.28e-05	0.000235	CcSEcCtD
Cyclophosphamide—Alopecia—Methotrexate—germ cell cancer	2.27e-05	0.000234	CcSEcCtD
Cyclophosphamide—CYP2B6—skin of body—germ cell cancer	2.26e-05	0.0154	CbGeAlD
Cyclophosphamide—Hypersensitivity—Etoposide—germ cell cancer	2.25e-05	0.000231	CcSEcCtD
Cyclophosphamide—Erythema—Methotrexate—germ cell cancer	2.24e-05	0.000231	CcSEcCtD
Cyclophosphamide—Dysgeusia—Methotrexate—germ cell cancer	2.19e-05	0.000226	CcSEcCtD
Cyclophosphamide—Asthenia—Etoposide—germ cell cancer	2.19e-05	0.000225	CcSEcCtD
Cyclophosphamide—Pruritus—Etoposide—germ cell cancer	2.16e-05	0.000222	CcSEcCtD
Cyclophosphamide—CYP2C8—pituitary gland—germ cell cancer	2.15e-05	0.0146	CbGeAlD
Cyclophosphamide—CYP2A6—brain—germ cell cancer	2.12e-05	0.0145	CbGeAlD
Cyclophosphamide—Vomiting—Cisplatin—germ cell cancer	2.12e-05	0.000218	CcSEcCtD
Cyclophosphamide—Vision blurred—Methotrexate—germ cell cancer	2.11e-05	0.000217	CcSEcCtD
Cyclophosphamide—Rash—Cisplatin—germ cell cancer	2.1e-05	0.000216	CcSEcCtD
Cyclophosphamide—Dermatitis—Cisplatin—germ cell cancer	2.1e-05	0.000216	CcSEcCtD
Cyclophosphamide—Diarrhoea—Etoposide—germ cell cancer	2.09e-05	0.000215	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Methotrexate—germ cell cancer	2.08e-05	0.000214	CcSEcCtD
Cyclophosphamide—Anaemia—Methotrexate—germ cell cancer	2.07e-05	0.000213	CcSEcCtD
Cyclophosphamide—Malaise—Methotrexate—germ cell cancer	2.02e-05	0.000208	CcSEcCtD
Cyclophosphamide—Dizziness—Etoposide—germ cell cancer	2.02e-05	0.000208	CcSEcCtD
Cyclophosphamide—Leukopenia—Methotrexate—germ cell cancer	2e-05	0.000206	CcSEcCtD
Cyclophosphamide—CYP2D6—brainstem—germ cell cancer	1.98e-05	0.0135	CbGeAlD
Cyclophosphamide—CYP2B6—gonad—germ cell cancer	1.98e-05	0.0135	CbGeAlD
Cyclophosphamide—Nausea—Cisplatin—germ cell cancer	1.98e-05	0.000204	CcSEcCtD
Cyclophosphamide—Cough—Methotrexate—germ cell cancer	1.95e-05	0.000201	CcSEcCtD
Cyclophosphamide—Convulsion—Methotrexate—germ cell cancer	1.94e-05	0.0002	CcSEcCtD
Cyclophosphamide—Vomiting—Etoposide—germ cell cancer	1.94e-05	0.0002	CcSEcCtD
Cyclophosphamide—Rash—Etoposide—germ cell cancer	1.92e-05	0.000198	CcSEcCtD
Cyclophosphamide—Dermatitis—Etoposide—germ cell cancer	1.92e-05	0.000198	CcSEcCtD
Cyclophosphamide—Headache—Etoposide—germ cell cancer	1.91e-05	0.000197	CcSEcCtD
Cyclophosphamide—CYP2C19—endocrine gland—germ cell cancer	1.91e-05	0.013	CbGeAlD
Cyclophosphamide—Myalgia—Methotrexate—germ cell cancer	1.9e-05	0.000196	CcSEcCtD
Cyclophosphamide—Chest pain—Methotrexate—germ cell cancer	1.9e-05	0.000196	CcSEcCtD
Cyclophosphamide—Arthralgia—Methotrexate—germ cell cancer	1.9e-05	0.000196	CcSEcCtD
Cyclophosphamide—Discomfort—Methotrexate—germ cell cancer	1.88e-05	0.000194	CcSEcCtD
Cyclophosphamide—Confusional state—Methotrexate—germ cell cancer	1.84e-05	0.00019	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Methotrexate—germ cell cancer	1.83e-05	0.000188	CcSEcCtD
Cyclophosphamide—Infection—Methotrexate—germ cell cancer	1.81e-05	0.000187	CcSEcCtD
Cyclophosphamide—Nausea—Etoposide—germ cell cancer	1.81e-05	0.000187	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Methotrexate—germ cell cancer	1.79e-05	0.000184	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Methotrexate—germ cell cancer	1.77e-05	0.000182	CcSEcCtD
Cyclophosphamide—CYP2D6—telencephalon—germ cell cancer	1.76e-05	0.012	CbGeAlD
Cyclophosphamide—Anorexia—Methotrexate—germ cell cancer	1.74e-05	0.000179	CcSEcCtD
Cyclophosphamide—CYP2B6—adrenal gland—germ cell cancer	1.72e-05	0.0117	CbGeAlD
Cyclophosphamide—Hypotension—Methotrexate—germ cell cancer	1.71e-05	0.000176	CcSEcCtD
Cyclophosphamide—CYP2C8—endocrine gland—germ cell cancer	1.67e-05	0.0113	CbGeAlD
Cyclophosphamide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	1.66e-05	0.000171	CcSEcCtD
Cyclophosphamide—Paraesthesia—Methotrexate—germ cell cancer	1.64e-05	0.000169	CcSEcCtD
Cyclophosphamide—Dyspnoea—Methotrexate—germ cell cancer	1.63e-05	0.000168	CcSEcCtD
Cyclophosphamide—CYP3A5—female gonad—germ cell cancer	1.62e-05	0.011	CbGeAlD
Cyclophosphamide—ABCB1—trigeminal ganglion—germ cell cancer	1.61e-05	0.011	CbGeAlD
Cyclophosphamide—CYP2C8—testis—germ cell cancer	1.59e-05	0.0108	CbGeAlD
Cyclophosphamide—Decreased appetite—Methotrexate—germ cell cancer	1.59e-05	0.000164	CcSEcCtD
Cyclophosphamide—Fatigue—Methotrexate—germ cell cancer	1.57e-05	0.000162	CcSEcCtD
Cyclophosphamide—Pain—Methotrexate—germ cell cancer	1.56e-05	0.000161	CcSEcCtD
Cyclophosphamide—ABCB1—embryo—germ cell cancer	1.56e-05	0.0106	CbGeAlD
Cyclophosphamide—Feeling abnormal—Methotrexate—germ cell cancer	1.5e-05	0.000155	CcSEcCtD
Cyclophosphamide—CYP3A5—endocrine gland—germ cell cancer	1.5e-05	0.0102	CbGeAlD
Cyclophosphamide—CYP2B6—endocrine gland—germ cell cancer	1.5e-05	0.0102	CbGeAlD
Cyclophosphamide—CYP2C9—endocrine gland—germ cell cancer	1.48e-05	0.0101	CbGeAlD
Cyclophosphamide—CYP2B6—head—germ cell cancer	1.48e-05	0.01	CbGeAlD
Cyclophosphamide—Urticaria—Methotrexate—germ cell cancer	1.45e-05	0.000149	CcSEcCtD
Cyclophosphamide—Body temperature increased—Methotrexate—germ cell cancer	1.44e-05	0.000149	CcSEcCtD
Cyclophosphamide—CYP2B6—testis—germ cell cancer	1.43e-05	0.0097	CbGeAlD
Cyclophosphamide—ABCB1—retina—germ cell cancer	1.38e-05	0.00937	CbGeAlD
Cyclophosphamide—Hypersensitivity—Methotrexate—germ cell cancer	1.35e-05	0.000139	CcSEcCtD
Cyclophosphamide—Asthenia—Methotrexate—germ cell cancer	1.31e-05	0.000135	CcSEcCtD
Cyclophosphamide—Pruritus—Methotrexate—germ cell cancer	1.29e-05	0.000133	CcSEcCtD
Cyclophosphamide—ABCB1—telencephalon—germ cell cancer	1.27e-05	0.00862	CbGeAlD
Cyclophosphamide—Diarrhoea—Methotrexate—germ cell cancer	1.25e-05	0.000129	CcSEcCtD
Cyclophosphamide—Dizziness—Methotrexate—germ cell cancer	1.21e-05	0.000124	CcSEcCtD
Cyclophosphamide—ABCB1—decidua—germ cell cancer	1.2e-05	0.00817	CbGeAlD
Cyclophosphamide—CYP2D6—female gonad—germ cell cancer	1.19e-05	0.00813	CbGeAlD
Cyclophosphamide—CYP2C8—brain—germ cell cancer	1.19e-05	0.00811	CbGeAlD
Cyclophosphamide—Vomiting—Methotrexate—germ cell cancer	1.16e-05	0.00012	CcSEcCtD
Cyclophosphamide—Rash—Methotrexate—germ cell cancer	1.15e-05	0.000119	CcSEcCtD
Cyclophosphamide—Dermatitis—Methotrexate—germ cell cancer	1.15e-05	0.000119	CcSEcCtD
Cyclophosphamide—Headache—Methotrexate—germ cell cancer	1.14e-05	0.000118	CcSEcCtD
Cyclophosphamide—CYP3A4—endocrine gland—germ cell cancer	1.13e-05	0.00768	CbGeAlD
Cyclophosphamide—CYP2D6—endocrine gland—germ cell cancer	1.11e-05	0.00756	CbGeAlD
Cyclophosphamide—CYP2D6—head—germ cell cancer	1.1e-05	0.00746	CbGeAlD
Cyclophosphamide—Nausea—Methotrexate—germ cell cancer	1.08e-05	0.000112	CcSEcCtD
Cyclophosphamide—CYP2B6—brain—germ cell cancer	1.07e-05	0.00728	CbGeAlD
Cyclophosphamide—CYP2D6—testis—germ cell cancer	1.06e-05	0.00721	CbGeAlD
Cyclophosphamide—ABCB1—gonad—germ cell cancer	1.06e-05	0.0072	CbGeAlD
Cyclophosphamide—ABCB1—uterus—germ cell cancer	1.05e-05	0.00715	CbGeAlD
Cyclophosphamide—ABCB1—pituitary gland—germ cell cancer	1.03e-05	0.00702	CbGeAlD
Cyclophosphamide—ABCB1—medulla oblongata—germ cell cancer	9.96e-06	0.00677	CbGeAlD
Cyclophosphamide—CYP2D6—cerebellum—germ cell cancer	9.79e-06	0.00666	CbGeAlD
Cyclophosphamide—ABCB1—adrenal gland—germ cell cancer	9.22e-06	0.00627	CbGeAlD
Cyclophosphamide—ABCB1—midbrain—germ cell cancer	9.1e-06	0.00619	CbGeAlD
Cyclophosphamide—ABCB1—bone marrow—germ cell cancer	8.92e-06	0.00607	CbGeAlD
Cyclophosphamide—ABCB1—spinal cord—germ cell cancer	8.88e-06	0.00604	CbGeAlD
Cyclophosphamide—ABCB1—female gonad—germ cell cancer	8.59e-06	0.00585	CbGeAlD
Cyclophosphamide—ABCB1—endocrine gland—germ cell cancer	7.99e-06	0.00544	CbGeAlD
Cyclophosphamide—CYP2D6—brain—germ cell cancer	7.95e-06	0.00541	CbGeAlD
Cyclophosphamide—ABCB1—head—germ cell cancer	7.89e-06	0.00537	CbGeAlD
Cyclophosphamide—ABCB1—testis—germ cell cancer	7.62e-06	0.00519	CbGeAlD
Cyclophosphamide—ABCB1—cerebellum—germ cell cancer	7.04e-06	0.00479	CbGeAlD
Cyclophosphamide—ABCB1—brain—germ cell cancer	5.72e-06	0.00389	CbGeAlD
Cyclophosphamide—ABCB1—lymph node—germ cell cancer	5.52e-06	0.00376	CbGeAlD
